Palliative care in metastatic head and neck cancer.

end of life care head and neck cancer metastatic cancer palliative care socioeconomic factors

Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
09 2021
Historique:
revised: 10 01 2021
received: 24 06 2020
accepted: 10 05 2021
pubmed: 22 5 2021
medline: 21 8 2021
entrez: 21 5 2021
Statut: ppublish

Résumé

Due to inherent impact on quality of life, metastatic head and neck cancer patients are well-suited to benefit from palliative care (PC). Our objective was to examine factors that shape PC utilization and implications for overall survival in stage IVc head and neck cancer patients. A retrospective study of patients with stage IVc head and neck cancer in the National Cancer Database from 2004 and 2015 was conducted. 7794 cases met inclusion criteria, of which 19.3% received PC. PC use was associated with more recent years of diagnosis, Northeast facility geography, and non-private insurances (p < 0.05). Compared to no PC, "interventional" PC, defined as palliative surgery, radiation, and/or chemotherapy, and "pain management only" PC were associated with lower overall survival (p < 0.05). PC use increased over time and was associated with demographic and clinical factors. There remains opportunity for improvement in optimal implementation of palliative care.

Sections du résumé

BACKGROUND
Due to inherent impact on quality of life, metastatic head and neck cancer patients are well-suited to benefit from palliative care (PC). Our objective was to examine factors that shape PC utilization and implications for overall survival in stage IVc head and neck cancer patients.
METHODS
A retrospective study of patients with stage IVc head and neck cancer in the National Cancer Database from 2004 and 2015 was conducted.
RESULTS
7794 cases met inclusion criteria, of which 19.3% received PC. PC use was associated with more recent years of diagnosis, Northeast facility geography, and non-private insurances (p < 0.05). Compared to no PC, "interventional" PC, defined as palliative surgery, radiation, and/or chemotherapy, and "pain management only" PC were associated with lower overall survival (p < 0.05).
CONCLUSIONS
PC use increased over time and was associated with demographic and clinical factors. There remains opportunity for improvement in optimal implementation of palliative care.

Identifiants

pubmed: 34018648
doi: 10.1002/hed.26761
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2764-2777

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. National treatment patterns in patients presenting with stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Med. 2015;4(12):1828-1835. https://doi.org/10.1002/cam4.546.
Liu JC, Bhayani M, Kuchta K, Galloway T, Fundakowski C. Patterns of distant metastasis in head and neck cancer at presentation: implications for initial evaluation. Oral Oncol. 2019;88:131-136. https://doi.org/10.1016/j.oraloncology.2018.11.023.
De Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope. 2000;110(3):397-401. https://doi.org/10.1097/00005537-200003000-00012.
Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994-1001. https://doi.org/10.1634/theoncologist.2009-0289.
Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114(5):806-816. https://doi.org/10.1002/ijc.20740.
Forbes K. Palliative care in patients with cancer of the head and neck. 1997;22(2):117-122. https://doi.org/10.1046/j.1365-2273.1997.00872.x.
Sesterhenn AM, Folz BJ, Bieker M, Teymoortash A, Werner JA. End-of-life care for terminal head and neck cancer patients. Cancer Nurs. 2008;31(2):E40-E46. https://doi.org/10.1097/01.ncc.0000305709.37530.a7.
Sciubba J. End-of-life care in the head and neck cancer patient. Oral Dis. 2016;22(8):740-744. https://doi.org/10.1111/odi.12506.
Nilsen ML, Johnson JT. Potential for low-value palliative care of patients with recurrent head and neck cancer. Lancet Oncol. 2017;18:e284-e289. https://doi.org/10.1016/s1470-2045(17)30260-7.
Haun M, Estel S, Rücker G, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017;2017(6):CD011129. https://doi.org/10.1002/14651858.CD011129.pub2/full.
Ferrell BR, Temel JS, Temin S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96-112. https://doi.org/10.1200/jco.2016.70.1474.
Shuman A, Yang Y, Taylor J, Prince M. End-of-life care among head and neck cancer patients. Otolaryngol Head Neck Surg. 2011;144(5):733-739. https://doi.org/10.1177/0194599810397603.
Schenker Y, Arnold RM, Bauman JE, Heron DE, Johnson JT. An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck cancer. Cancer. 2016;122(3):340-343. https://doi.org/10.1002/cncr.29754.
Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S198-S207. https://doi.org/10.1017/s0022215116000633.
Begbie F, Douglas C, Finlay F, Montgomery J. Palliative intent treatment for head and neck cancer: an analysis of practice and outcomes. J Laryngol Otol. 2019;133(4):313-317. https://doi.org/10.1017/S0022215119000574.
Mulvey CL, Smith TJ, Gourin CG. Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer. Nead Neck. 2016;38(3):355-363. https://doi.org/10.1002/hed.23895.
Winchester DP, Stewart AK, Phillips JL, Ward EE. The National Cancer Data Base: past, present, and future. Ann Surg Oncol. 2010;17(1):4-7. https://doi.org/10.1245/s10434-009-0771-3.
Surgeons ACo. National Cancer Data Base [Database Online]. 2020. http://www.facs.org/cancer/ncdb/index.html
Carey RM, Godovchik J, Workman AD, et al. Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma. Int Forum Allergy Rhinol. 2017;7(12):1186-1194. https://doi.org/10.1002/alr.22027.
Carey RM, Parasher AK, Workman AD, et al. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: analysis from the national cancer database. Laryngoscope. 2018;128(3):560-567. https://doi.org/10.1002/lary.26804.
Carey RM, Fathy R, Shah RR, et al. Association of Type of treatment facility with overall survival after a diagnosis of head and neck cancer. JAMA Netw Open. 2020;3(1):e1919697. https://doi.org/10.1001/jamanetworkopen.2019.19697.
Growth of Palliative Care in U.S. Hospitals: 2018 Snapshot (2000-2016). Center to Advance Palliative Care (CAPC). Accessed 22 April 2020. https://media.capc.org/filer_public/27/2c/272c55c1-b69d-4eec-a932-562c2d2a4633/capc_2018_growth_snapshot_022118.pdf
Dumanovsky T, Augustin R, Rogers M, Lettang K, Meier DE, Morrison RS. The growth of palliative Care in U.S. hospitals: a status report. J Palliat Med. 2016;19(1):8-15. https://doi.org/10.1089/jpm.2015.0351.
Palliative Care (Version 1.2020). 2020. Accessed 22 April 2020. https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf
Osagiede O, Colibaseanu D, Spaulding A, et al. Palliative care use among patients with solid cancer tumors: a National Cancer Data Base Study. J Palliat Care. 2018;33(3):149-158. https://doi.org/10.1177/0825859718777320.
Roeland EJ, Triplett DP, Matsuno RK, et al. Patterns of palliative care consultation among elderly patients with cancer. J Natl Compr Canc Netw. 2016;14(4):439-445. https://doi.org/10.6004/jnccn.2016.0050.
Colibaseanu DT, Osagiede O, Spaulding AC, et al. The determinants of palliative care use in patients with colorectal cancer: a National Study. Am J Hosp Palliat Med. 2018;35(10):1295-1303. https://doi.org/10.1177/1049909118765092
de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck. 2000;22(4):398-407. https://doi.org/10.1002/1097-0347(200007)22:4<398::aid-hed14>3.0.co;2-v.
Triplett DP, Lebrett WG, Bryant AK, et al. Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer. J Oncol Pract. 2017;13(9):e760-e769. https://doi.org/10.1200/jop.2017.020883.
Mack JW, Cronin A, Keating NL, et al. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol. 2012;30(35):4387-4395. https://doi.org/10.1200/jco.2012.43.6055.
Colombet I, Bouleuc C, Piolot A, et al. Multicentre analysis of intensity of care at the end-of-life in patients with advanced cancer, combining health administrative data with hospital records: variations in practice call for routine quality evaluation. BMC Palliat Care. 2019;18(1):35. https://doi.org/10.1186/s12904-019-0419-4.
Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742. https://doi.org/10.1056/nejmoa1000678.
Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research. Med Care. 2010;48:S114-S120. https://doi.org/10.1097/mlr.0b013e3181dbebe3.
Mohanty S, Bilimoria KY. Comparing national cancer registries: the National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J Surg Oncol. 2014;109(7):629-630. https://doi.org/10.1002/jso.23568.
Standards for Oncology Registry Entry. STORE 2018 2018. Accessed 29 January 2020. https://www.facs.org/-/media/files/quality-programs/cancer/ncdb/store_manual_2018.ashx
Facility Oncology Registry Data Standards (FORDS) 2020: Revised for 2016. Accessed 1/29/2020. https://www.facs.org/quality-programs/cancer/ncdb/call-for-data/fordsmanual
Commission on Cancer. A Quality Program of the American College of Surgeons. Standards and Resources. 2020 Accessed 31 January 2020. https://www.facs.org/quality-programs/cancer/coc/standards/2020
Janz TA, Graboyes EM, Nguyen SA, et al. A comparison of the NCDB and SEER database for research involving head and neck cancer. Otolaryngol Head Neck Surg. 2019;160(2):284-294. https://doi.org/10.1177/0194599818792205.
Davaro FM, Weinstein D, Siddiqui SA, Hamilton ZA. A lack of palliative therapy use in patients with advanced penile cancer. J Palliat Care. 2020;36(2):98-104. https://doi.org/10.1177/0825859720946887.
Kim S, Diperi TP, Guan M, et al. Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World J Gastrointest Surg. 2020;12(9):377-389. https://doi.org/10.4240/wjgs.v12.i9.377.

Auteurs

Alyssa M Civantos (AM)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Aman Prasad (A)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Ryan M Carey (RM)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Andrés M Bur (AM)

Department of Otolaryngology: Head and Neck Surgery, University of Kansas, Kansas City, Kansas, USA.

Leila J Mady (LJ)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Robert M Brody (RM)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Karthik Rajasekaran (K)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Steven B Cannady (SB)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Lee Hartner (L)

Department of Hematology, Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Said A Ibrahim (SA)

Department of Healthcare Policy & Research, Weill Cornell Medicine, New York, New York, USA.

Jason G Newman (JG)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Jason A Brant (JA)

Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH